Loading clinical trials...
Loading clinical trials...
StrataPATH™ (Precision Indications for Approved Therapies): A Study Evaluating the Clinical Activity and Safety of Approved Drugs Within Biomarker-Guided Patients With Solid Tumors
Conditions
Interventions
lorlatinib
encorafenib + binimetinib
+5 more
Locations
4
United States
Florida Cancer Specialists - North
St. Petersburg, Florida, United States
Florida Cancer Specialists - Panhandle
Tallahassee, Florida, United States
Kettering Health Network
Kettering, Ohio, United States
University of Wisconsin
Madison, Wisconsin, United States
Start Date
April 29, 2022
Primary Completion Date
June 12, 2024
Completion Date
June 12, 2024
Last Updated
January 8, 2025
NCT06498635
NCT05884320
NCT05198830
NCT05245812
NCT04929028
NCT06842498
Lead Sponsor
Strata Oncology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions